CooperCompanies Announces Upcoming Q3 2025 Financial Results
CooperCompanies, a significant player in the medical device industry, has announced its plans to disclose its financial results for the third quarter of 2025. This eagerly anticipated release will occur on a Wednesday at 4:15 PM ET, providing insights into the company's performance and operations.
Details of the Earnings Call
Following the financial report, CooperCompanies will conduct a comprehensive conference call at 5:00 PM ET. This call will cover not just the financial results but also discuss ongoing developments within the company. Analysts and stakeholders can expect insightful commentary from the executive team about the company’s strategies moving forward.
How to Participate in the Conference Call
For those wishing to join the conference call, the dial-in number is 800-715-9871, with a designated conference ID of 3665386 provided for identification purposes. For convenience, an audio webcast will be available, allowing participants to engage with the information in real-time or access a replay afterward.
About CooperCompanies
CooperCompanies operates with a mission to enhance people's experiences through its two primary business units: CooperVision and CooperSurgical. CooperVision is recognized for its leadership in the contact lens sector, striving to improve daily vision for countless individuals. Meanwhile, CooperSurgical is dedicated to women's healthcare and fertility solutions, making significant impacts during critical healthcare moments for families and women. The company, headquartered in California, employs over 16,000 individuals and serves markets in more than 130 countries, making a positive contribution to the lives of over fifty million people worldwide each year.
Recent Developments and Growth
Amidst constant shifts in the healthcare landscape, CooperCompanies remains focused on innovation and development. The company's commitment to research and expansion helps them maintain a competitive edge in the medical device market. Recent advancements in technologies related to vision and women's health highlight their dedication to improving patient outcomes. Furthermore, their global presence signifies the trust placed in them by consumers and healthcare professionals alike.
Contact Information
For investor inquiries, please reach out to Kim Duncan, Vice President of Investor Relations and Risk Management at 925-460-3663. For additional communication, inquiries can be sent via email to ir@cooperco.com.
Frequently Asked Questions
When is the Q3 2025 earnings report being released?
The Q3 2025 earnings report will be released on a Wednesday at 4:15 PM ET.
How can I participate in the earnings call?
To join the earnings call, dial 800-715-9871 and use conference ID 3665386.
What products does CooperCompanies provide?
CooperCompanies is known for its innovative contact lenses through CooperVision and fertility products via CooperSurgical.
Where is CooperCompanies headquartered?
CooperCompanies is headquartered in California and operates in over 130 countries worldwide.
How many people does CooperCompanies impact each year?
CooperCompanies positively impacts over fifty million lives each year through its various healthcare initiatives.
